Jubilant Pharmova Ltd (nse:JUBLPHARMA) Share Price

Company Profile

Business description
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.
Contact
1A, Sector 16A
NoidaUP201301
IND
T: +91 1204361000
https://www.jubilantpharmova.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
5,750

Recommended

The market is underestimating the clear path to profitability.

Roy van Keulen | 14 January 2025

Shares drop 17% after guidance is revised but we still see value.

Shane Ponraj | 09 January 2025

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.

Joseph Taylor | 09 January 2025

Index	Last price	Change	% Change
All Ordinaries	8,456.80	15.00	-0.18%
CAC 40	7,462.04	38.37	0.52%
DAX 40	20,440.85	169.52	0.84%
Dow JONES (US)	42,518.28	221.16	0.52%
FTSE 100	8,266.10	64.56	0.79%
HKSE	19,286.07	66.29	0.34%
NASDAQ	19,044.39	43.71	-0.23%
Nikkei 225	38,444.58	29.72	-0.08%
NZX 50 Index	12,943.57	59.19	0.46%
S&P 500	5,842.91	0.00	0.00%
S&P/ASX 200	8,213.30	17.70	-0.22%
SSE Composite Index	3,227.12	13.82	-0.43%